Volume 57, Issue 1, Pages (January 2000)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 62, Pages S12-S22 (December 2002)
Volume 65, Issue 1, Pages (January 2004)
Volume 62, Issue 1, Pages (July 2002)
Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
Osteopontin expression in acute renal allograft rejection
Volume 81, Issue 11, Pages (June 2012)
Osteopontin expression in human crescentic glomerulonephritis
Volume 54, Issue 6, Pages (January 1998)
Volume 76, Issue 1, Pages (July 2009)
Volume 68, Issue 6, Pages (December 2005)
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 4, Pages (October 2000)
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 1, Pages (July 2003)
Volume 61, Issue 2, (February 2002)
Volume 65, Issue 1, Pages (January 2004)
Volume 62, Issue 6, Pages (December 2002)
Volume 54, Issue 3, Pages (September 1998)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 69, Issue 1, Pages (January 2006)
Volume 59, Issue 5, Pages (May 2001)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 55, Issue 4, Pages (April 1999)
Volume 73, Issue 12, Pages (June 2008)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 63, Issue 5, Pages (May 2003)
Volume 57, Issue 2, Pages (October 2000)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 64, Pages S39-S45 (October 2003)
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 2, Pages (February 2003)
Volume 64, Issue 3, Pages (September 2003)
Volume 55, Issue 2, Pages (February 1999)
Volume 53, Issue 5, Pages (May 1998)
Volume 61, Issue 6, Pages (June 2002)
Volume 60, Issue 1, Pages (July 2001)
Volume 55, Issue 2, Pages (February 1999)
Renal fibroblast-like cells in Goodpasture syndrome rats
Volume 64, Pages S64-S70 (October 2003)
Volume 64, Issue 3, Pages (September 2003)
Volume 59, Issue 3, Pages (March 2001)
Osteopontin in diabetic nephropathy: signpost or road?
Expression of connective tissue growth factor in human renal fibrosis
Volume 57, Issue 3, Pages (March 2000)
Volume 74, Issue 4, Pages (August 2008)
Volume 73, Issue 9, Pages (May 2008)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 62, Pages S12-S22 (December 2002)
The Case | Idiopathic hypocomplementemic interstitial nephritis
Volume 75, Issue 6, Pages (March 2009)
Volume 62, Issue 2, Pages (August 2002)
Volume 70, Issue 8, Pages (October 2006)
Volume 64, Pages S21-S26 (October 2003)
Volume 68, Issue 5, Pages (November 2005)
CD4+ T cells: a potential player in renal fibrosis
Macrophages and progressive tubulointerstitial disease
Tubulointerstitial damage and progression of renal failure
Volume 69, Issue 11, Pages (June 2006)
Why is proteinuria an ominous biomarker of progressive kidney disease?
Volume 58, Issue 4, Pages (October 2000)
Volume 59, Issue 5, Pages (May 2001)
Volume 69, Issue 10, Pages (May 2006)
Volume 67, Issue 6, Pages (June 2005)
The more or less ‘pristine’ renal allograft biopsy
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 75, Issue 8, Pages (April 2009)
Volume 56, Issue 3, Pages (September 1999)
Volume 75, Issue 2, Pages (January 2009)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 57, Issue 1, Pages 147-158 (January 2000) Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy  Sergio A. Mezzano, M.D., M. Alejandra Droguett, M. Eugenia Burgos, Leopoldo G. Ardiles, Claudio A. Aros, Italo Caorsi, Jesús Egido  Kidney International  Volume 57, Issue 1, Pages 147-158 (January 2000) DOI: 10.1046/j.1523-1755.2000.00830.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Demonstration of monocyte chemoattractant protein-1 (MCP-1) mRNA by in situ hybridization (ISH), RANTES protein, and osteopontin (OPN) protein by immunohistochemistry in idiopathic membranous nephritis (IMN; magnification ×300). (a) MCP-1 mRNA is strongly up-regulated and mainly expressed by tubular epithelial cells in progressive IMN (case 12). (b) MCP-1 mRNA is weakly expressed in tubular epithelial cells in a nonprogressive IMN (case 25). (c) RANTES protein staining is strongly increased in proximal tubular epithelial cells in progressive IMN (case 10). (d) On the other hand, RANTES is weakly increased in tubular cells in a nonprogressive case of IMN (case 24). (e) Strong overexpression of osteopontin protein in tubular epithelial cells in progressive IMN (case 13). Note the interstitial cell infiltration in close relationship with the tubular osteopontin expression. (f) Negative staining for osteopontin in tubular epithelial cells in case of nonprogressive IMN16. Kidney International 2000 57, 147-158DOI: (10.1046/j.1523-1755.2000.00830.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Demonstration of platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β) by ISH, and α-smooth muscle actin (α-SMA) by immunohistochemistry in IMN (magnification ×300). (a) Strong up-regulation of PDGF mRNA in tubular epithelial cells in progressive IMN (case 5). (b) Weak up-regulation of PDGF mRNA in tubular epithelial cells in non progressive IMN (case 16). (c) Strong up-regulation of TGF-β mRNA in tubular epithelial cells in progressive case of IMN (case 2). (d) TGF-β mRNA is not up-regulated in nonprogressive IMN case (case 23). (e) Moderate increase in interstitial myofibroblats (α-SMA positive cells in renal interstitium) in a progressive IMN case (case 4). (f) Weak peritubular staining for α-SMA in a case of nonprogressive IMN (case 23). Kidney International 2000 57, 147-158DOI: (10.1046/j.1523-1755.2000.00830.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 (a) Demonstration of MCP-1 mRNA and (b) protein in progressive IMN (case 11; magnification ×300). Serial sections of the same biopsy show that MCP-1 mRNA (a) and protein (b) are strongly expressed in tubular epithelial cells. The distribution of MCP-1 mRNA and protein is similar. (c) Immunohistochemistry coupled with ISH for α-SMA positive cells and TGF-β. A moderate increase in interstitial α-SMA is associated with TGF-β mRNA up-regulation in close tubular epithelial cells. (d) CD68-positive cells in progressive IMN (case 10). Paraffin section (magnification ×300). (e) CD4+ T-cell lymphocytes in renal interstitium (case 13). Cryostat section (magnification ×300). (f) CD8+ T-cell lymphocytes in interstitium (case 13). Cryostat section (magnification ×300). Kidney International 2000 57, 147-158DOI: (10.1046/j.1523-1755.2000.00830.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Schematic summary of chemokines, profibrogenic cytokines, and α-SMA expression in progressive (□) and nonprogressive IMN (). The results of the IMH or ISH staining scores are presented as the mean ± SEM. *P < 0.05. Kidney International 2000 57, 147-158DOI: (10.1046/j.1523-1755.2000.00830.x) Copyright © 2000 International Society of Nephrology Terms and Conditions